These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

192 related articles for article (PubMed ID: 29190165)

  • 61. The regression time of ocular surface squamous neoplasia using topical interferon alfa-2b does not depend on the initial tumor size.
    Vilaltella M; Huerva V
    Arq Bras Oftalmol; 2021; 85(2):109-114. PubMed ID: 34431893
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Long-Term Efficacy and Safety of Subconjunctival/Perilesional 5-Fluorouracil Injections for Ocular Surface Squamous Neoplasia.
    Sun Y; Hua R
    Drug Des Devel Ther; 2020; 14():5659-5665. PubMed ID: 33376309
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of Ocular Surface Squamous Neoplasia and Conjunctival Squamous Cell Carcinoma among Ugandan Patients: A Hospital-based Study.
    Lloyd HCM; Arunga S; Twinamasiko A; Frederick MA; Onyango J
    Middle East Afr J Ophthalmol; 2018; 25(3-4):150-155. PubMed ID: 30765953
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Recombinant Interferon Alpha-2b as Primary Treatment for Ocular Surface Squamous Neoplasia.
    Ghaffari R; Barijani S; Alivand A; Latifi G; Ghassemi H; Zarei-Ghanavati M; Djalilian AR
    J Curr Ophthalmol; 2021; 33(3):260-265. PubMed ID: 34765812
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Adjuvant treatment or primary topical monotherapy for ocular surface squamous neoplasia: a systematic review.
    Viani GA; Fendi LI
    Arq Bras Oftalmol; 2017; 80(2):131-136. PubMed ID: 28591290
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Ocular Surface Squamous Neoplasia With Coexistent Microbial Keratitis: Incidence, Risk Factors, Clinical Features, Microbiological Profile, and Treatment Outcome.
    Kapoor AG; Vempuluru VS; Laghimshetty S; Roy A; Sharma S; Mishra DK; Mohamed A; Kaliki S
    Cornea; 2022 Mar; 41(3):294-303. PubMed ID: 34294636
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Subconjunctival/perilesional recombinant interferon α2b for ocular surface squamous neoplasia: a 10-year review.
    Karp CL; Galor A; Chhabra S; Barnes SD; Alfonso EC
    Ophthalmology; 2010 Dec; 117(12):2241-6. PubMed ID: 20619462
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Surgical versus medical treatment for ocular surface squamous neoplasia: A quality of life comparison.
    Mercado CL; Pole C; Wong J; Batlle JF; Roque F; Shaikh N; Murillo JC; Galor A; Karp CL
    Ocul Surf; 2019 Jan; 17(1):60-63. PubMed ID: 30217629
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Ocular surface squamous neoplasia in xeroderma pigmentosum: clinical spectrum and outcome.
    Gupta N; Sachdev R; Tandon R
    Graefes Arch Clin Exp Ophthalmol; 2011 Aug; 249(8):1217-21. PubMed ID: 21484462
    [TBL] [Abstract][Full Text] [Related]  

  • 70. Management of diffuse ocular surface squamous neoplasia: efficacy and complications of topical chemotherapy.
    Rudkin AK; Dempster L; Muecke JS
    Clin Exp Ophthalmol; 2015; 43(1):20-5. PubMed ID: 24995542
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Topical medical therapies for ocular surface tumors.
    Poothullil AM; Colby KA
    Semin Ophthalmol; 2006; 21(3):161-9. PubMed ID: 16912014
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Intralesional bevacizumab use for invasive ocular surface squamous neoplasia.
    Paul S; Stone DU
    J Ocul Pharmacol Ther; 2012 Dec; 28(6):647-9. PubMed ID: 22900896
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Treatment of conjunctival squamous neoplasias with interferon alpha 2ab.
    Huerva V; Mangues I
    J Fr Ophtalmol; 2008 Mar; 31(3):317-25. PubMed ID: 18404128
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Topical chemotherapy for ocular surface squamous neoplasia.
    Nanji AA; Sayyad FE; Karp CL
    Curr Opin Ophthalmol; 2013 Jul; 24(4):336-42. PubMed ID: 23680759
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-term outcomes after adjunctive topical 5-flurouracil or mitomycin C for the treatment of surgically excised, localized ocular surface squamous neoplasia.
    Bahrami B; Greenwell T; Muecke JS
    Clin Exp Ophthalmol; 2014; 42(4):317-22. PubMed ID: 23927413
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Recurrence of Ocular Surface Squamous Neoplasia Treated With Excisional Biopsy and Cryotherapy.
    Li AS; Shih CY; Rosen L; Steiner A; Milman T; Udell IJ
    Am J Ophthalmol; 2015 Aug; 160(2):213-219.e1. PubMed ID: 25914042
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Treatment outcome with interferon alpha 2b in ocular surface squamous neoplasia: Recommendation as primary treatment by peripheral ophthalmologists.
    Meel R; Dhiman R; Vanathi M; Sen S; Gupta N; Tandon R
    Oman J Ophthalmol; 2021; 14(1):27-32. PubMed ID: 34084031
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Prevalence and Severity of Ocular Surface Neoplasia in African Nations and Need for Early Interventions.
    Reynolds JW; Pfeiffer ML; Ozgur O; Esmaeli B
    J Ophthalmic Vis Res; 2016; 11(4):415-421. PubMed ID: 27994810
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Ocular surface squamous neoplasia: management and outcomes.
    Hӧllhumer R; Williams S; Michelow P
    Eye (Lond); 2021 Jun; 35(6):1562-1573. PubMed ID: 33564137
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Perilesional and topical interferon alfa-2b for conjunctival and corneal neoplasia.
    Vann RR; Karp CL
    Ophthalmology; 1999 Jan; 106(1):91-7. PubMed ID: 9917787
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.